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ABSTRACT 
PURPOSE: To evaluate the effects of an intraperitoneal solution of methylene blue (MB), lidocaine and pentoxyphylline (PTX) on 
intestinal ischemic and reperfusion injury 
METHODS: Superior mesenteric artery was isolated and clamped in 36 adult male Sprague Dawley rats. After 60 minutes, clamp 
was removed and a group received intraperitoneally UNITO solution (PTX 25mg/kg + lidocaine 5mg/kg + MB 2mg/kg), while the 
other group was treated with warm 0.9% NaCl solution. Rats were euthanized 45 min after drug administration. Lung and bowel were 
collected for histological evaluation (using Park’s score) and determination of myeloperoxidase (MPO) and malondialdehyde (MDA) 
levels.  
RESULTS: Control samples showed lymphoplasmocytic infiltrate and crypt necrosis of villi.  MPO and MDA measurements shown no 
differences between treated and control groups. 
CONCLUSION: The combination of lidocaine, methylene blue and pentoxyphylline administered intraperitoneally at the studied dose, 
did not decreased histological lesion scores and biochemical markers levels in intestinal ischemia/reperfusion injury.
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Introduction
Intestinal I/R injury is a common pathologic event 
associated with many intestinal pathologies, whenever the intestine 
undergoes a reduction with subsequent restoration (usually during 
surgery) of blood flow1-5. Spontaneous I/R can occur in humans 
and if the diagnosis is made within 24h after the onset of symptoms 
and aggressive treatment initiated, acute mesenteric ischemia has 
about a 50% survival rate, whereas this rate drops to 30% or less 
when diagnosis is delayed6. In experimental models, it has been 
shown that the extent of mucosal damage is a direct function 
of time elapsed from the onset of mesenteric artery occlusion 
with first histological changes after 30 min and more prominent 
destruction of the villi after 60 min7. After revascularization, 
mucosal regeneration via cell migration occurs rapidly, even after 
90 min of ischemia8. 
Several authors investigated the I/R phenomenon and 
tried therapeutic approaches but in the majority of these it was 
not possible to identify a single compound completely capable to 
prevent and solve I/R damages, but the combination of some drugs 
seemed to suggest a synergic effect that enhance protection, acting 
on different phases of this process5.
Pentoxifylline (PTX), a methylxanthine derivative 
known for many years for its rheological properties, has proven 
to be a potent inhibitor of tumor necrosis factor (TNF) production. 
It has been suggested that PTX can enhance the chemotactic 
response of neutrophils, but may inhibit phagocytosis and the 
superoxide production by neutrophils and monocytes. It has also 
been shown that this drug has beneficial effects in patients with 
lung I/R injury. The potential local effects are important for acute 
lung injury manifestation by inflammatory mediators that are 
blood- and lymph-borne, and oxygen-free radical activations10. 
Methylene blue (MB) is an inexpensive drug used to 
treat diseases such as methaemoglobinemia and Alzheimer’s and 
has been proposed for use in vasoplegic shock during sepsis, 
cardiopulmonary bypass surgery and liver transplantation. 
However, MB is known to enhance key biochemical pathways 
in mithocondria, and cycling between oxidized and reduced MB 
forms might block oxidant production11. 
Lidocaine is widely used as a local anesthetic, but has 
been recently administered systemically in horses to treat post 
operative ileus. It is known that local anesthetic agents modulate 
the inflammatory response via mechanisms unrelated to sodium 
channel blockade. Lidocaine has been shown to reduce cytokines 
release and inhibit neutrophil function. Additionally, in studies 
evaluating its effect on I/R injury in other organs, lidocaine has 
been shown to reduce lipid peroxidation attributable to oxidant 
release and inhibit neutrophil adhesion and migration12. It has been 
also demonstrated to inhibit neutrophils migration13.
Taking into consideration the previous studies, it was 
hypothesized that a mixture of pentoxifylline, lidocaine and 
methylene blue could be useful in prevention and treatment of 
intestinal I/R injury. For this purpose we used an animal model of 
intestinal I/R in which the superior mesenteric artery occlusion-
reperfusion simulates the I/R injury that may occur in clinical 
situations, and investigated the effects of the combination of drugs 
on bowel and lungs. 
Methods
The study was approved by the Bioethical committee of 
the University of Turin and by the Italian Ministry of Health. 
Thirty-six Sprague-Dawley adult male rats, body weights 
of 300 grams (270-310 grams), were kept in standard conditions 
and fed standard rat chow for 5 days before the experiment. 
Twelve hours before surgery they were fasted but water allowed 
ad libitum. Anesthesia was induced by a single intramuscular 
injection of xylazine (0.025 ml/kg) and ketamine (25 mg/rat), and 
the abdomen shaved and aseptically prepared with 10% povidone 
iodine. Upon a 2.5-cm midline laparotomy, the superior mesenteric 
artery was isolated at its origin and occluded with an atraumatic 
microvascular clamp for 60 min. To ensure a complete ischemia, 
collateral arteries were blocked using an encircling ligature with 
Prolene USP 4-0 suture. At the end of ischemia period the clamp 
and ligatures were removed and reperfusion was confirmed by 
restoration of the pulsations and the normal gut color. The animals 
were randomly assigned with a random calculator (www.random.
org) to two groups: treated (T) and control (C). In group T, 18 
rats were treated with 1 ml of the solution (UNITO solution) 
composed by PTX (25mg/kg), lidocaine (5 mg/kg) and MB 
(6 mg/kg) diluted in warm 0.9% NaCl solution administered 
intraperitoneally. In group C, 18 rats were administered  1 ml of 
warm 0.9% NaCl solution intraperitoneally. Experiments were 
made in 6 different sessions involving 3 rats per each group. After 
45 min of reperfusion, rats were euthanized by cervical vertebrae 
dislocation. 
Samples collection
Lungs and bowel samples were collected and stored in 
formalin or at -80°C for biochemical analysis.Histology
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Samples were fixed in buffered formalin, embedded in 
paraffin, and 4-μm tissue sections were stained with hematoxylin-
eosin (HE). The slides were independently evaluated by two 
histopathologists blinded to the group assignation. To evaluate 
tissue damages, Park’s score was used14 (Chart 1).
CHART 1 - Description of the histological scoring 
system after Park and Chiu8.
0 Normal mucosa
1 Subepithelial space at villus tips
2 Extension of subepithelial space with moderate lifting
3 Massive lifting down sides of villi, some denuded tips
4 Denuded villi, dilated capillaries
5 Disintegration of lamina propria
6 Crypt layer injury
7 Transmucosal infarction
8 Transmural infarction 
Biochemical analysis
The biochemical analysis consisted in myeloperoxidase 
(MPO) and malondialdehyde (MDA) activity evaluation 
according, respectively, to the methods proposed by Muià et al.15 
and Hei et al.16, but introducing some minor modifications. 
MPO
MPO activity was measured both in lung and intestine. 
Aliquots of 500 mg of frozen tissues were homogenated in potassium 
phosphate buffer (PPB) (10 mM and pH 7) and 0.5% (w/v) hexa- 
decyltrimethyl-ammonium bromide (CTAB, Sigma Aldrich, 
Italy), and centrifuged at 20.000 x g for 30 min at 4°C. Fifty µL 
of surnatant were incubated with 950 µL of tetramethylbenzidine 
(TMB plus, Kem-EN-Ten Diagostic, Denmark) and rate of change 
in absorbance was measured at 650 nm. 
MDA
MDA content was measured in intestine samples. Tissues 
homogenate (50 µL) were incubated with 50 µL 8.1% sodium 
dodecyl sulfate (SDS, Sigma Aldrich, Italy), 400 µL acetic acid 
buffer (Sigma Aldrich, Italy), 400 µL 0.8% thiobarbituric acid 
(TBA, Sigma Aldrich, Italy) and 100 µL distilled water. 
Aliquots of of 1,1,3,3-tetraethoxypropane (Sigma 
Aldrich, Italy) were used as positive control. 
Then all the tubes were incubated at 95°C for 1 h. After 
cooled at -20 for 5 min, 1 mL n-butyl alcohol (Sigma Aldrich, 
Italy) was added into the sample, which was centrifuged for 10 
min at 800 x g. The supernatant of the samples was taken to detect 
absorbance at 533 nm with spectrophotometer. To determine the 
concentration we used a molar extinction coefficient for MDA of 
1.56 x105 cm-1M-1. Results were expressed as nmol MDA/100mg 
protein17.
Statistical analysis
All data are presented as mean ± standard error (SEM). 
Normality of data was assessed with the Kolmogornov-Smirnoff 
test. Differences for histological score comparison were analyzed 
with a Mann Whitney test. Unpaired T-test was performed to 
analyze biochemical results. Statistical analyses were performed 
by GraphPad InStat (vers. 3.05) statistical software (GraphPad 
Inc.). The Grubbs test was used to reveal potential outliers, which 
were excluded. A value of p<0.05 was considered to be statistically 
significant.
Results
During the experiment, two rats of treated group died 
during recovery from anesthesia.
Histology
Histological score for the control group was 3.4 ± 0.6817 
while in the treated group was 2.47 ± 0.6537. The difference was 
not statistically significant (p=0.3242).
Malondialdehyde level in the intestine was not 
significantly different (p=0.2884) between control (88.3 ± 27.234 
nmol/100mg) and treated I/R group (80.28 ± 14.802 nmol/100 
mg).
The MPO activity in the intestine did not differ 
significantly (p=0.6834) between treated (1.156±0.35 mU/g) and 
control group (1.349±0.39 mU/g).
The MPO activity in the lung was not significantly 
different (p=0.5686) between control (3.06±0.497 mU/g) and 
treated I/R group (3.235±0.583 mU/g). 
Discussion
The results of the present study highlighted that the 
UNITO solution (mixture of PXT, MB and lidocaine) is not 
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effective against I/R injuries when administered intraperitoneally. 
Analysis of the data showed that MPO and MDA increased in all 
the tested samples without significant differences between groups.
In the authors’ best knowledge, this was the first time that 
this combination was used. The authors’ hypothesis was that these 
substances could have a synergic effect on I/R bowel and lung 
injuries. This hypothesis was supported by the bibliography that 
showed a huge number of papers dealing with the experimental 
success of single molecule trial, suggesting a further clinical 
application. 
The study of Marqui et al.10 demonstrated that 
pentoxifylline has preventive effects and therapeutic potential 
in I/R-induced lung injuries, but the same authors are carefull 
to suggest a direct application while the clinical relevance of 
that manuscript referred to the use of pentoxifylline in situations 
requiring procedures of ischemia with reperfusion to reduce 
or prevent distant organs damage. The study of Seifi et al.18 
showed that PTX and N- Acetilcysteine (NAC) administered 
intraperitoneally protected kidney tissue against oxidative 
damage caused by experimental induced hepatic I/R. Kalay et 
al.19 and Lloris Carsi et al.1 demonstrated the beneficial effects of 
intraperitoneally administered pentoxyphilline on intestinal injury 
after ischemic and reperfusion event in an in vivo animal model.
The study of Salehi et al.20 demonstrate that a treatment 
with a amino acid-based (AA) solution could reduce neutrophil 
infiltration in tissues reperfused after 30 min of ischemic event, 
indicating the possibility of lower graft immunogenicity over this 
time frame. Presumably, reduced neutrophil localization implies 
a decrease of chemotactic factors and influencing reduction of 
neutrophils attraction to the site of injury. Although diminished 
neutrophil recruitment supports the link between I/R injury and 
inflammatory response, additional adjunctive therapies involving 
anti-inflammatory agents seem to be required to fully protect the 
injured mucosa during inflammatory attack following I/R. The 
study of Berger et al.13 demonstrated that systemic administration of 
lidocaine arrest transmigration of neutrophils through endothelial 
cells and the results obtained by Elhakim et al.21 demonstrated that 
intraperitoneal lidocaine enhance bowel recovery after surgery. 
First in 1988, Kelner et al.22, reviewing the mechanisms 
of action of methylene blue, observed that it could be used to 
inhibit the production of superoxides in ischemic tissues. For the 
same reason this molecule was chosen in other experiments23-26 
and in the present study. On the other side, the study of Miranda 
et al.27 demonstrated that MB infusion had not beneficial effect 
on the healing of intestinal anastomoses in an experimental I/R 
model in rats. 
Seen these previous works we hypothesized that a 
combination of these molecules could have a synergic effect on 
different aspects of I/R injuries in intestines and lungs. The scarce 
efficacy of the mixture could be due to different causes.
First, the dosage of each component in the mixture has 
been extrapolated from previous literature. By testing other doses 
of each components, results could be different. 
Second, the intraperitoneal administration may be 
effective for some of the components, but not for others. 
Lidocaine, for instance, has been extensively tested for intravenous 
administration, and very little for intraperitoneal administration. 
Although intraperitoneal absorption can be comparable to 
intravenous absorption for some drugs, this could be not the case 
for lidocaine. 
Third, I/R injury involves complex pathways and 
many of these could not be targeted by the intraperitoneal route. 
Last possibility is that instead of having a synergic effect, the 
combination of these molecules has a counter effective effect on 
the efficacy of all or some of them.
Further studies should be conducted to evaluate these 
limits, considering different dosages and different routes of 
administration.
Conclusion
The combination of lidocaine, methylene blue and 
pentoxyphylline administered intraperitoneally at the dose hereby 
presented, did not significantly decreased histological lesion scores 
and biochemical markers levels in intestinal ischemia/reperfusion 
injury.
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